Detalles de la búsqueda
1.
Systemic complement levels in patients with age-related macular degeneration carrying rare or low-frequency variants in the CFH gene.
Hum Mol Genet;
31(3): 455-470, 2022 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34508573
2.
Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration.
Am J Hum Genet;
108(8): 1367-1384, 2021 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34260947
3.
LASER FLARE PHOTOMETRY IN PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT: An Evaluation of 2,487 Cases.
Retina;
44(5): 764-773, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181515
4.
Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy.
Nature;
552(7684): 248-252, 2017 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29211719
5.
INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Retina;
43(3): 379-388, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36727801
6.
A mega-analysis of expression quantitative trait loci in retinal tissue.
PLoS Genet;
16(9): e1008934, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32870927
7.
Analysis of hemopexin plasma levels in patients with age-related macular degeneration.
Mol Vis;
28: 536-543, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-37089696
8.
The Phenotypic Course of Age-Related Macular Degeneration for ARMS2/HTRA1: The EYE-RISK Consortium.
Ophthalmology;
129(7): 752-764, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35240203
9.
Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical Trial.
Ophthalmology;
129(10): 1129-1141, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35680097
10.
EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Retina;
42(4): 721-729, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864802
11.
Ocular and Systemic Complement Activation during Anti-Vascular Endothelial Growth Factor Treatment and Age-Related Eye Disease Study 2 Dietary Supplementation in Neovascular Age-Related Macular Degeneration.
Ophthalmologica;
245(3): 258-264, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34034256
12.
Increased pro-MMP9 plasma levels are associated with neovascular age-related macular degeneration and with the risk allele of rs142450006 near MMP9.
Mol Vis;
27: 142-150, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33907369
13.
Genetic and environmental risk factors for reticular pseudodrusen in the EUGENDA study.
Mol Vis;
27: 757-767, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35136347
14.
Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe: The EYE-RISK Consortium.
Ophthalmology;
128(7): 1039-1049, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33253757
15.
Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium.
Ophthalmology;
128(11): 1604-1617, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32717343
16.
Association of imaging biomarkers and local activation of complement in aqueous humor of patients with early forms of age-related macular degeneration.
Graefes Arch Clin Exp Ophthalmol;
259(3): 623-632, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32876798
17.
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy.
Graefes Arch Clin Exp Ophthalmol;
259(4): 905-910, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33119804
18.
SALIVARY ALPHA-AMYLASE LEVELS MAY CORRELATE WITH CENTRAL SEROUS CHORIORETINOPATHY ACTIVITY.
Retina;
41(12): 2479-2484, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34292222
19.
RESPONSE OF CHOROIDAL ABNORMALITIES TO PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Place Trial Report No. 4.
Retina;
41(10): 2122-2131, 2021 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543244
20.
New Technologies in Clinical Trials in Corneal Diseases and Limbal Stem Cell Deficiency: Review from the European Vision Institute Special Interest Focus Group Meeting.
Ophthalmic Res;
64(2): 145-167, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32634808